Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Stopped Study recruitment was halted prematurely as widespread vaccination of the study population made completion infeasible.

Conditions

• COVID-19
• Viral Respiratory Illnesses

Interventions

• DRUG: Nitazoxanide
• DRUG: Placebo
• DIETARY_SUPPLEMENT: Vitamin Super B-Complex

Sponsor

Romark Laboratories L.C.